Astrea Bioseparations to Combine with Biotage AB, Creating Global Chromatography Leader
February 15, 2023
Menlo Park, CA – Gamma Biosciences (“Gamma”), a global life sciences platform formed by KKR to address the advanced therapy market with best-in-class bioprocessing solutions, today announced that it has entered into an agreement with Swedish life sciences company Biotage AB (STO: BIOT) (“Biotage”), whereby Biotage will acquire Gamma’s operating company, Astrea Bioseparations (“Astrea”), in [...]
February 15, 2023
Strong strategic fit extending chromatography franchise into the attractive bioprocessing market serving biologics and advanced therapeutic customers Uppsala, Sweden – Biotage AB (publ) (“Biotage”) has entered into an agreement to acquire Astrea Bioseparations (“Astrea”), a high-growth chromatography solutions provider from Gamma Biosciences (“Gamma”), a life sciences tools platform created by KKR. The acquisition also includes [...]
GREINER BIO-ONE OPENS NEW SALES OFFICE IN DUBAI
February 15, 2023
On February 7, 2023, Greiner Bio-One officially opened its new sales office in the Dubai Science Park. The official opening marks a milestone in the successful establishment of the new sales office. Greiner Bio-One's management and sales managers attended the festive event. The new office becomes one of the 29 international locations of Greiner Bio-One. [...]
First of its kind to receive ACT environmental impact score
February 15, 2023
It began with a question: What if we could have more transparency into the environmental impact of our products? Now, the first 30 products from Cytiva’s filtration product line have recently received ACT labels — providing clear, third-party verified information of the impact these products have on the environment. Cytiva is the first vendor to [...]
BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
February 14, 2023
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) and Cell Signaling Technology (CST) announced today the addition of Simple Western™ validation to CST antibodies. This will allow researchers in various disciplines an easier way to study important molecular signaling pathways on a trusted and validated platform. Obtaining accurate data efficiently and fast is key to advancing drug discovery and development. [...]
CSols Inc. Launches Data and Analytics Services
February 14, 2023
NEWARK, DE, UNITED STATES — CSols Inc., the premier informatics consultancy in North America, announces the addition of new Data and Analytics service offerings. Organizations can leverage CSols’s expertise within and beyond the laboratory to enhance their decision-making capabilities. This addition of services, coupled with CSols’s deep domain understanding of life science data, provides an end-to-end service [...]
February 14, 2023
SAN DIEGO & JENA, Germany -- Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Analytik Jena today announced a co-marketing agreement that will allow the companies to promote applications of their combined laboratory automation technologies that will enable customers to accelerate and optimize their scientific research. Biosero and Analytik Jena will [...]
February 14, 2023
DNA Studio 4 Vault builds on the leading bioprinting software and transforms cumbersome processes riddled with administrative paperwork into the digital era. Providing users with confidence and trust in their documentation, enabling a faster translation from the research lab to the clinic. A significant challenge in translational research is ensuring the proper scaling of pre-clinical [...]
Eppendorf: New production site in Shanghai metropolitan region
February 13, 2023
Contract for new plant in Pinghu signed Centrifuge business to be bolstered in the growth market of China Local supply chain to simplify logistics and reduce transport emissions Shanghai/Hamburg – The globally positioned Eppendorf Group is expanding its production operation in the Chinese market. The company signed a contract for a new production site in [...]
February 13, 2023
NeuroMatrix™ will enable labs to grow a large range of mature, biologically relevant neurons – derived from non-embryonic stem cells (iPSCs) – to advance drug discovery, toxicity testing and next generation human therapeutic use. SAN ANTONIO -- StemBioSys Inc. (StemBioSys) announced today the launch of NeuroMatrix™, an astrocyte-derived extracellular matrix that enables the culture of human induced pluripotent stem cell [...]
